RxDoctor Payments Data

Bailey Zaruba

Psychiatric/Mental Health · Cedar Rapids, IANPI 1053099051

Payments from drug & device makers

$2,577in general payments, 2019–2025

Across 150 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$475
  • Otsuka America Pharmaceutical, Inc.$318
  • Supernus Pharmaceuticals, Inc.$292
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$259
  • Neurocrine Biosciences, Inc.$222
  • Alkermes, Inc.$193
  • plus $819 from 12 others

What the payments were for

  • Food & beverage$2,577100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,577 in reported general payments places this provider in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$21,465
Medicare patients
70
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate93$302,761
VraylarCariprazine Hcl77$104,028
RexultiBrexpiprazole35$36,893
TrintellixVortioxetine Hydrobromide15$7,319
Paliperidone ErPaliperidone42$5,646
AzstarysSerdexmethylphen/Dexmethylphen14$5,596
Aripiprazole98$3,143
Duloxetine Hcl141$2,139
Quetiapine Fumarate160$2,111
Clozapine19$2,108
Lurasidone Hcl16$2,049
Bupropion XlBupropion Hcl76$1,723
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine29$1,714
Hydroxyzine Pamoate88$1,562
Buspirone Hcl92$1,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$142$302,76193 claims
AbbVieVraylar$475$104,02877 claims
Otsuka America Pharmaceutical, Inc.Rexulti$318$36,89335 claims
Corium, LLCAzstarys$51$5,59614 claims
Almatica Pharma LLCSertraline Hcl$32$1,325169 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →